Across the biotech industry, the demand for accelerated time to clinic, operational precision, and robust scalability has never been more critical. Developers face the complexity of solving a growing ...

As the life sciences industry contends with tighter economic conditions and increasing investor scrutiny, integrated innovation partners (IIPs) are emerging as a more effective model than traditional ...

The therapeutic landscape is shifting—and biomarkers are at the center of this transformation. In this exclusive session, we’ll spotlight high-impact protein targets including FOLR1, HER2, Claudin ...

Protein therapeutics play a pivotal role across the modern healthcare landscape, offering treatment options for a wide range of indications. To meet the increased demand for these therapies, it is ...

North Carolina is an ideal location for companies to grow and thrive. The state has what you need to accelerate new therapies to market, from world-class research to scientific expertise, from talent ...

Researchers are exploring the effectiveness of combining antibody drug conjugates and immune checkpoint inhibitors in non-small cell lung cancer. Precision medicine has improved the prognosis for ...

Discover the patterns that emerge from real-world CDx development and post-approval projects. Struggling to achieve the widespread adoption of your precision medicine therapy? The missing piece might ...

In this executive summary, Catalent Cell & Gene Therapy experts George Buchman, Ph.D., Research Fellow, and Bhargavi Kondragunta, Ph.D., Director, Internal R&D and Product Development, explain ...

The resilience in Biopharma is facing a downturn. The 2023 Global Biopharma Resilience Index from Cytiva offers insights into the industry's current state, spotlighting both strong points and ...

With an increase in the number of clinical trials for gene-based therapies, there is an increase in genetic screening to identify patients for trials, stratify patients and ensure the safety of ...

Life sciences entrepreneurship is a high-risk path. You've got vision, discipline and determination. But your company also needs a supportive environment and resources to grow. You need mentoring, ...

The unprecedented changes in regulatory compliance, technological advancements, product cycle times, need for market access and international expansion have forced medical device companies to take a ...